Bo Zerahn

2.8k total citations
112 papers, 1.9k citations indexed

About

Bo Zerahn is a scholar working on Surgery, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Bo Zerahn has authored 112 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Surgery, 23 papers in Oncology and 19 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Bo Zerahn's work include Total Knee Arthroplasty Outcomes (17 papers), Nutrition and Health in Aging (14 papers) and Orthopaedic implants and arthroplasty (13 papers). Bo Zerahn is often cited by papers focused on Total Knee Arthroplasty Outcomes (17 papers), Nutrition and Health in Aging (14 papers) and Orthopaedic implants and arthroplasty (13 papers). Bo Zerahn collaborates with scholars based in Denmark, Sweden and United States. Bo Zerahn's co-authors include Marie Øbro Fosbøl, Helle Westergren Hendel, Jens Faber, Pernille Højman, Hakon Kofoed, Julie Gehl, Inge‐Lis Kanstrup, Caroline Kistorp, Anders Vinther and Anders Holsgaard‐Larsen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Bo Zerahn

109 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Zerahn Denmark 25 554 476 431 255 210 112 1.9k
G. Gamble New Zealand 25 458 0.8× 254 0.5× 318 0.7× 263 1.0× 372 1.8× 53 2.1k
Antonios Stavropoulos‐Kalinoglou United Kingdom 32 185 0.3× 365 0.8× 291 0.7× 470 1.8× 295 1.4× 66 3.0k
Francesco Ursini Italy 26 273 0.5× 279 0.6× 196 0.5× 100 0.4× 342 1.6× 134 2.4k
Elisabeth M. W. Eekhoff Netherlands 29 601 1.1× 333 0.7× 349 0.8× 130 0.5× 558 2.7× 122 2.7k
Gert Hein Germany 29 387 0.7× 345 0.7× 349 0.8× 94 0.4× 534 2.5× 113 2.9k
Andrea Giusti Italy 27 872 1.6× 268 0.6× 488 1.1× 451 1.8× 232 1.1× 89 2.4k
Micha J. Rapoport Israel 24 514 0.9× 208 0.4× 185 0.4× 94 0.4× 396 1.9× 122 2.3k
Alfredo Santana Spain 30 644 1.2× 514 1.1× 119 0.3× 363 1.4× 713 3.4× 86 2.4k
Symeon Tournis Greece 24 289 0.5× 394 0.8× 454 1.1× 94 0.4× 337 1.6× 96 1.8k
Bong Yun South Korea 23 839 1.5× 418 0.9× 190 0.4× 239 0.9× 533 2.5× 80 2.5k

Countries citing papers authored by Bo Zerahn

Since Specialization
Citations

This map shows the geographic impact of Bo Zerahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Zerahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Zerahn more than expected).

Fields of papers citing papers by Bo Zerahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Zerahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Zerahn. The network helps show where Bo Zerahn may publish in the future.

Co-authorship network of co-authors of Bo Zerahn

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Zerahn. A scholar is included among the top collaborators of Bo Zerahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Zerahn. Bo Zerahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pedersen, Michael Lynge, Thomas Alexander Gerds, Nanette Mol Debes, et al.. (2025). How to identify children with cerebral palsy at risk of low bone mineral density. Bone. 197. 117515–117515.
2.
Wolsk, Emil, Morten Schou, Mads Ersbøll, et al.. (2024). Coronary Microvascular Dysfunction and Left Heart Filling Pressures in Patients with Type 2 Diabetes. ESC Heart Failure. 11(6). 3551–3558. 4 indexed citations
3.
Overgaard, Karsten, Bo Zerahn, Maria Pedersen, et al.. (2024). Beneficial effects of exercise, testosterone, vitamin D, calcium and protein in older men—A randomized clinical trial. Journal of Cachexia Sarcopenia and Muscle. 15(4). 1451–1462. 9 indexed citations
4.
Rasmussen, Rune Skovgaard, Bo Zerahn, Maria Pedersen, et al.. (2024). Testosterone and resistance training improved physical performance and reduced fatigue in frail older men: 1 year follow-up of a randomized clinical trial. The Aging Male. 27(1). 2403519–2403519. 3 indexed citations
5.
Ammitzbøll, Gunn, Ole Hyldegaard, Charlotte Lanng, et al.. (2023). Effects of an early intervention with Hyperbaric Oxygen Treatment on arm lymphedema and quality of life after breast cancer—an explorative clinical trial. Supportive Care in Cancer. 31(5). 313–313. 1 indexed citations
6.
Schou, Morten, Philip Hasbak, Andreas Kjær, et al.. (2023). The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 25(10). 2888–2896. 9 indexed citations
7.
Wolsk, Emil, Morten Schou, Mads Ersbøll, et al.. (2022). Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE Trial. Diabetes. 71(4). 812–820. 6 indexed citations
8.
Schou, Morten, Philip Hasbak, Andreas Kjær, et al.. (2021). Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial. Journal of the American Heart Association. 10(15). e020418–e020418. 22 indexed citations
9.
10.
Zerahn, Bo, et al.. (2020). Decreased markers of bone turnover in children and adolescents with type 1 diabetes. Pediatric Diabetes. 21(3). 505–514. 31 indexed citations
11.
Ammitzbøll, Gunn, Kenneth Geving Andersen, Pernille Envold Bidstrup, et al.. (2019). Effect of progressive resistance training on persistent pain after axillary dissection in breast cancer: a randomized controlled trial. Breast Cancer Research and Treatment. 179(1). 173–183. 27 indexed citations
12.
Ammitzbøll, Gunn, Trille Kristina Kjær, Christoffer Johansen, et al.. (2019). Effect of progressive resistance training on health-related quality of life in the first year after breast cancer surgery – results from a randomized controlled trial. Acta Oncologica. 58(5). 665–672. 31 indexed citations
13.
14.
Holsgaard‐Larsen, Anders, et al.. (2018). Postoperative effects of progressive resistance training prior to total hip arthroplasty – one year outcome of a randomized controlled trial. Osteoarthritis and Cartilage. 26. S330–S331. 1 indexed citations
15.
Hendel, Helle Westergren, et al.. (2017). Reference Values for Assessment of Unilateral Limb Lymphedema with Dual-Energy X-Ray Absorptiometry. Lymphatic Research and Biology. 16(1). 75–84. 13 indexed citations
16.
Ammitzbøll, Gunn, Charlotte Lanng, Niels Kroman, et al.. (2017). Progressive strength training to prevent LYmphoedema in the first year after breast CAncer – the LYCA feasibility study. Acta Oncologica. 56(2). 360–366. 25 indexed citations
17.
18.
Nielsen, Dorte, et al.. (2007). Anthracycline-induced chronic cardiotoxicity and heart failure. Acta Oncologica. 46(5). 576–580. 28 indexed citations
19.
Zerahn, Bo, Gunnar Schwarz Lausten, & Inge‐Lis Kanstrup. (2004). Prospective comparison of differences in bone mineral density adjacent to two biomechanically different types of cementless femoral stems. International Orthopaedics. 28(3). 146–150. 10 indexed citations
20.
Petersen, Michael Mørk, et al.. (2003). The precision and influence of rotation for measurements of bone mineral density of the distal femur following total knee arthroplastyA methodological study using DEXA. Acta Orthopaedica Scandinavica. 74(6). 677–682. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Gamble Breakdown of academic impact, for papers by Antonios Stavropoulos‐Kalinoglou Breakdown of academic impact, for papers by Francesco Ursini Breakdown of academic impact, for papers by Elisabeth M. W. Eekhoff Breakdown of academic impact, for papers by Gert Hein Breakdown of academic impact, for papers by Andrea Giusti Breakdown of academic impact, for papers by Micha J. Rapoport Breakdown of academic impact, for papers by Alfredo Santana Breakdown of academic impact, for papers by Symeon Tournis Breakdown of academic impact, for papers by Bong Yun
Rankless by CCL
2026